[1] |
发热伴血小板减少综合征诊疗方案(2023年版)[J].中国感染控制杂志,2024,23(7):918-920.
|
[2] |
陈秋兰, 朱曼桐, 陈宁, 等.2011-2021年全国发热伴血小板减少综合征流行特征分析[J].中华流行病学杂志,2022,43(6):852-859.
|
[3] |
孙玉兰, 王志越, 宋丽君, 等.北京市首例发热伴血小板减少综合征本土病例的调查[J].国际病毒学杂志,2021,28(6):472-474.
|
[4] |
Sun Y, Zhang D, Liu H, et al.The flrst reported cases of severe fever with thrombocytopenia syndrome virus from domestic sick camel to humans in China[J].Emerg Microbes Infect,2024,13(1):2309990.
|
[5] |
陈广, 陈韬, 舒赛男, 等.重症发热伴血小板减少综合征诊治专家共识[J].传染病信息,2022,35(5):385-393.
|
[6] |
葛子若, 田地, 陈志海.发热伴血小板减少综合征的临床特征与分期和分型研究进展[J].中国医药,2020,15(7):1149-1152.
|
[7] |
袁义美, 崔宁, 袁春.发热伴血小板减少综合征命名, 临床分期及分型的建议[J].中华传染病杂志,2016,34(1):57-58.
|
[8] |
李德新.发热伴血小板减少综合征布尼亚病毒概述[J].中华实验和临床病毒学杂志,2011,25(2):81-84.
|
[9] |
葛子若, 田地, 陈志海.发热伴血小板减少综合征死亡危险因素及预警模型研究进展[J].传染病信息,2020,33(5):462-465.
|
[10] |
Xiong WY, Feng ZJ, Matsui T, et al.Risk assessment of human infection with a novel bunyavirus in China[J].Western Pac Surveill Response J,2012,3(4):61-66.
|
[11] |
刘均艳, 冯江, 李阿利, 等.发热伴血小板减少综合征布尼亚病毒感染患者临床诊治及死亡危险因素分析[J].中国医师进修杂志,2018,41(5):429-433.
|
[12] |
杨振东, 秦书理, 赵普宇, 等.发热伴血小板减少综合征重症及死亡危险因素的Logistic回归分析[J].国际流行病学传染病学杂志,2015,42(2):115-119.
|
[13] |
Liu MM, Lei XY, Yu XJ.Meta-analysis of the clinical and laboratory parameters of SFTS patients in China[J].Virol J,2016;13(1):198.
|
[14] |
Guo CT, Lu QB, Ding SJ, et al.Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis[J].Epidemiol Infect,2016,144(6):1345-1354.
|
[15] |
Gai ZT, Zhang Y, Liang MF, et al.Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients[J].J Infect Dis,2012,206(7):1095-1102.
|
[16] |
赵海燕, 孙静, 严晓敏, 等.发热伴血小板减少综合征患者的临床特点及死亡相关危险因素分析[J].中华传染病杂志,2016,34(1):15-18.
|
[17] |
Li H, Lu QB, Xing B, et al.Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study[J].Lancet Infect Dis,2018,18(10):1127-1137.
|
[18] |
尚振德, 孙密密, 孙即奎, 等.发热伴血小板减少综合征并发脑室出血及侵袭性肺曲霉菌病一例临床分析[J/CD].中华实验和临床感染病杂志(电子版),2017,11(1):101-104.
|
[19] |
Kaneko M, Shikata H, Matsukage S, et al.A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system[J].J Infect Chemother,2018,24(4):292-297.
|
[20] |
孙娜, 陈志海.发热伴血小板减少综合征患者的血液及免疫系统损伤[J/CD].中华实验和临床感染病杂志(电子版),2018,12(6):538-542.
|
[21] |
Xiong L, Xu L, Lv X, et al.Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A singlecenter retrospective cohort study[J].Int J Infect Dis,2022,122:1026-1033.
|
[22] |
Wang F, Wu Y, Jiao J, et al.Risk factors and clinical characteristics of severe fever with thrombocytopenia syndrome[J].Int J Gen Med,2020,13:1661-1667.
|
[23] |
张海滨, 刘小伟, 倪秀莹, 等.59例老年发热伴血小板减少综合征多器官功能障碍患者的临床分析[J/CD].中华实验和临床感染病杂志(电子版),2017,11(1):69-72.
|
[24] |
Li S, Li Y, Wang Q, et al.Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical flnding in a fatal case[J].Virol J,2018,15(1):97.
|
[25] |
金聪, 韩颖, 李川, 等.发热伴血小板减少综合征病毒感染Balb/C小鼠和金黄地鼠的免疫病理反应[J].病毒学报,2015,31(4):379-387.
|
[26] |
Park ES, Shimojima M, Nagata N, et al.Severe fever with thrombocytopenia syndrome phlebovirus causes lethal viral hemorrhagic fever in cats[J].Sci Rep,2019,9(1):11990.
|
[27] |
王桐, 王俊忠, 郑昕.发热伴血小板减少综合征病毒感染导致多器官损伤的病理特征[J].中华传染病杂志,2024,42(4):249-252.
|
[28] |
Liu Z, Jiang Z, Zhang L, et al.A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome[J].Front Microbiol,2024,14:1307960.
|
[29] |
Liu Z, Zhang R, Zhou W, et al.High levels of C-reactive protein-toalbumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage[J].J Med Virol,2022,94(11):5375-5384.
|
[30] |
Liu Z, Ge Z, Pan W, et al.Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A singlecenter cohort study[J].Int Immunopharmacol,2024,136:112288.
|
[31] |
Park A, Park SJ, Jung KL, et al.Molecular signatures of inflammatory profile and B-cell function in patients with severe fever with thrombocytopenia syndrome[J].mBio,2021,12(1):e02583-20.
|
[32] |
Kawaguchi T, Umekita K, Yamanaka A, et al.Corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: A case-control study[J].Viruses,2021,13(5):785.
|
[33] |
Jung SI, Kim YE, Yun NR, et al.Effects of steroid therapy in patients with severe fever with thrombocytopenia syndrome: a multicenter clinical cohort study[J].PLoS Negl Trop Dis,2021,15(2):e0009128.
|
[34] |
Wang G, Xu YL, Zhu Y, et al.Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study[J].Int J Infect Dis,2023,130:153-160.
|
[35] |
Kutsuna S, Ohbe H, Matsui H, et al.Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: Retrospective analysis with overlap weighting using a national inpatient database[J].J Infect Chemother,2023,29(5):490-494.
|
[36] |
夏鹏, 蒋陈晓, 颜霄迪, 等.糖皮质激素在发热伴血小板减少综合征患者中的应用进展[J].药学与临床研究,2024,32(4):349-354.
|
[37] |
Yuan F, Zhu L, Tian D, et al.The first discovery of severe fever with thrombocytopenia virus in the center of metropolitan Beijing,China[J].Virol Sin,2024,39(6):875-881.
|